Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Odd Erik Johansen

1-50 of 61 results

View this query on the Wikidata Query Service
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

scientific article
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes

scientific article published on 14 June 2016
Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus

scientific article published on December 13, 2013
Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial

scientific article
SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials

scientific article published on January 14, 2015
The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus

scientific article published on January 29, 2014
Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme

scientific article published on January 10, 2012
How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial

scientific article published on 4 December 2017
Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA®)

scientific article
Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™)

scientific article
Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies

scientific article published on 14 December 2011
Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME® trial

scientific article published on February 1, 2018
Empagliflozin reduces body weight and indices of adipose distribution in patients with type 2 diabetes mellitus

scientific article published on March 1, 2016
Cardiovascular safety of linagliptin in type 2 diabetes: a comprehensive patient-level pooled analysis of prospectively adjudicated cardiovascular events

scientific article published on May 21, 2015
Safety and Tolerability of Linagliptin in Patients With Type 2 Diabetes: A Comprehensive Pooled Analysis of 22 Placebo-controlled Studies

scientific article published on July 8, 2014
Pooled analysis of Phase III trials indicate contrasting influences of renal function on blood pressure, body weight, and HbA1c reductions with empagliflozin

scientific article published on 28 August 2017
Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk

scientific article
Impact of Empagliflozin on Blood Pressure in Patients With Type 2 Diabetes Mellitus and Hypertension by Background Antihypertensive Medication

scientific article published on 10 October 2016
Prevalence of abnormal glucose metabolism in atrial fibrillation: a case control study in 75-year old subjects

scientific article published on 28 September 2008
Interleukin-6 and activin A are independently associated with cardiovascular events and mortality in type 2 diabetes: the prospective Asker and Bærum Cardiovascular Diabetes (ABCD) cohort study

scientific article published on August 30, 2013
Determinants and prognostic implications of Cardiac Troponin T measured by a sensitive assay in Type 2 Diabetes Mellitus

scientific article published on September 15, 2010
Effects of structured hospital-based care compared with standard care for Type 2 diabetes-The Asker and Baerum Cardiovascular Diabetes Study, a randomized trial

scientific article published on 17 May 2007
Exenatide may aggravate moderate diabetic renal impairment: a case report

scientific article published on 15 May 2008
Diurnal Glycemic Patterns during an 8-Week Open-Label Proof-of-Concept Trial of Empagliflozin in Type 1 Diabetes

scientific article published on November 6, 2015
Defining the role of repaglinide in the management of type 2 diabetes mellitus: a review

scientific article published on January 2007
Undiagnosed dysglycaemia and inflammation in cardiovascular disease

scientific article published in August 2006
Potential role of sodium glucose cotransporter 2 inhibitors in the treatment of hypertension

scientific article
Rationale and design of the CAROLINA® - cognition substudy: a randomised controlled trial on cognitive outcomes of linagliptin versus glimepiride in patients with type 2 diabetes mellitus

scientific article published on 15 January 2018
Effect of Linagliptin on Cognitive Performance in Patients With Type 2 Diabetes and Cardiorenal Comorbidities: The CARMELINA Randomized Trial

scientific article published on 09 August 2019
Comparison of Adipose Distribution Indices with Gold Standard Body Composition Assessments in the EMPA-REG H2H SU Trial: A Body Composition Sub-Study

scientific article published on November 25, 2015
Preventing macrovascular disease in patients with type 2 diabetes mellitus

scientific article (publication date: 2003)
Identification of a definite diabetic cardiomyopathy in type 2 diabetes by comprehensive echocardiographic evaluation: A cross-sectional comparison with non-diabetic weight-matched controls

scientific article published on 28 October 2014
Inflammation and coronary angiography in asymptomatic type 2 diabetic subjects

scientific article
Cardiovascular Mortality Reduction With Empagliflozin in Patients With Type 2 Diabetes and Cardiovascular Disease

scientific article published in January 2018
Efficacy and Cardiovascular Safety of Linagliptin as an Add-On to Insulin in Type 2 Diabetes: A Pooled Comprehensive Post Hoc Analysis

scientific article published on October 21, 2015
Diabetic foot ulcer burden may be modified by high-dose atorvastatin: A 6-month randomized controlled pilot trial

scientific article published on 2 June 2009
Interpretation of cardiovascular outcome trials in type 2 diabetes needs a multiaxial approach

scientific article published on August 10, 2015
Safety and efficacy of linagliptin in patients with type 2 diabetes mellitus and coronary artery disease: Analysis of pooled events from 19 clinical trials

scientific article published on 16 June 2016
The heart failure burden of type 2 diabetes mellitus-a review of pathophysiology and interventions

scientific article
Impact of empagliflozin on blood pressure in dipper and non-dipper patients with type 2 diabetes mellitus and hypertension

scientific article
Heart rate adjustments and analysis of recovery patterns of ST-segment depression in type 2 diabetes

scientific article published on 25 May 2007
Rationale for low-dose systemic hormone replacement therapy and review of estradiol 0.5 mg/NETA 0.1 mg.

scientific article published on June 2008
Low-dose CT coronary angiography for assessment of coronary artery disease in patients with type 2 diabetes - A cross-sectional study

scientific article published on November 14, 2015
Neutral impact on systolic and diastolic cardiac function of 2 years of intensified multi-intervention in type 2 diabetes: The randomized controlled Asker and Bærum Cardiovascular Diabetes (ABCD) study

scientific article published on June 9, 2014
Empagliflozin in women with type 2 diabetes and cardiovascular disease - an analysis of EMPA-REG OUTCOME®.

scientific article
Changing basal insulin from NPH to detemir or glargine in patients with type 1 diabetes and a history of severe hypoglycemia

scientific article published on 08 April 2009
FDA guidance on antihyperglyacemic therapies for type 2 diabetes: One decade later

scientific article published on 12 March 2019
Correction to: Comparison of Adipose Distribution Indices with Gold Standard Body Composition Assessments in the EMPA-REG H2H SU Trial: A Body Composition Sub-Study

scientific article
Long-term follow-up of a hospital-based, multi-intervention programme in type 2 diabetes mellitus: impact on cardiovascular events and death

scientific article published on January 2017
Asymptomatic coronary artery disease in a Norwegian cohort with type 2 diabetes: a prospective angiographic study with intravascular ultrasound evaluation

scholarly article by Satish Arora et al published 9 March 2019 in Cardiovascular Diabetology

Paulina is supported by:

About Paulina

Help